Clinical characteristics of African-American men with heriditary prostate cancer: The AAHPC study

Prostate Cancer and Prostatic Diseases

Volumn 7, Issue 2, 2004, Pages 165-169

  Ahaghotu, C ^a,b   Baffoe Bonnie, A ^c,j   Kittles, R ^a,b   Pettaway, C ^d   Powell, I ^e   Royal, C ^a,b   Wang, H ^c   Vijayakumar, S ^f   Bennett, J ^g   Hoke, G ^h   Mason, T ⁱ   Bailey Wilson, J ^j   Boykin, W ^g   Berg, K ^j   Carpten, J ^k   Weinrich, S ^l   Trent, J ^k   Dunston, G ^a,b   Collins, F ^j  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HOWARD UNIVERSITY   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g Midtown Urology   (United States)

^h New York Presbyterian Hospital Columbia University Medical Center   (United States)

ⁱ MICHAEL REESE HOSPITAL   (United States)

^j NATIONAL INSTITUTES OF HEALTH   (United States)

^k TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^l UNIVERSITY OF SOUTH CAROLINA   (United States)

more..

Author keywords

African Americans; Heriditary prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SEX HORMONE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER GRADING; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; EARLY DIAGNOSIS; FAMILIAL CANCER; FAMILY HISTORY; FISHER EXACT TEST; FOLLOW UP; GENETIC RISK; HISTOLOGY; HORMONAL THERAPY; HUMAN; LINKAGE ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NONPARAMETRIC TEST; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM; SOCIAL PSYCHOLOGY; STATISTICAL SIGNIFICANCE; WILCOXON SIGNED RANKS TEST;

AFRICAN AMERICANS; AGE OF ONSET; AGED; COHORT STUDIES; DECISION MAKING; FAMILY HEALTH; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PEDIGREE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 3142664016     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500719     Document Type: Article

References (30)

1. Clegg L et al. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med 2002; 162: 1985-1993.
2. Zeigler-Johnson C. CYP3A4: a potential prostate cancer risk factor for high-risk groups. Clin J Oncol Nurs 2001; 5: 153-154.
3. Powell IJ, Meyskens Jr FL. African-American men and hereditary/familial prostate cancer: Intermediate-risk populations for chemoprevention trials. Urology 2001; 57 (Suppl 1): 178-181.
4. Cunningham GR et al. Familial aggregation of prostate cancer in African-Americans and white Americans. Prostate 2003; 56: 256-262.
5. Narain V, Cher ML, Wood Jr DP. Prostate cancer diagnosis, staging and survival. Cancer Metastasis Rev 2002; 21: 17-27.
6. Ries L et al. (eds). SEER Cancer Statistics Review, 1973-1999. National Cancer Institute: Bethesda, MD 2002.
7. Carter BS et al. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992; 89: 3367-3371.
8. Cooney KA et al. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst 1997; 89: 955-959.
9. Cooney KA. Hereditary prostate cancer in African-American families. Semin Urol Oncol 1998; 16: 202-206.
10. Carter BS et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993; 150: 797-802.
11. Royal C et al. Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Ann Epidemiol 2000; 10 (Suppl 8): S68-S77.
12. AJCC. American Joint Committee on Cancer AJCC Cancer Staging Manual, 5th Edn. Lippincott-Raven: Philadelphia 1997.
13. Gleason D. Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum (ed), Urologic Pathology: The Prostate. Lea and Febiger: Philadelphia 1987; pp. 107-160.
14. Goode EL et al. Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci. Clin Cancer Res 2001; 7: 2739-2749.
15. Smith JR et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996; 274: 1371-1374.
16. Paiss T et al. Association between the clinical presentation and epidemiological features of familial prostate cancer in patients selected for radical prostatectomy. Eur Urol 2003; 43: 615-621.
17. Bova GS et al. Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy. J Urol 1998; 160 (Part 1): 660-663.
18. Schleutker J et al. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease. Clin Cancer Res 2000; 6: 4810-4815.
19. Keetch DW et al. Clinical and pathological features of hereditary prostate cancer. J Urol 1996; 155: 1841-1843.
20. Gronberg H et al. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA 1997; 278: 1251-1255.
21. Bratt O, Damber JE, Emanuelsson M, Gronberg H. Hereditary prostate cancer: clinical characteristics and survival. J Urol 2002; 167: 2423-2426.
22. Bauer JJ et al. Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy. Urology 1998; 51: 970-976.
23. Nippon S et al. An analysis of familial prostate cancer. Nippon Hinyokika Gakkai Zasshi. 1995; 86: 1483-1487.
24. Bastacky SI et al. Pathological features of hereditary prostate cancer. J Urol 1995; 153 (Part 2): 987-992.
25. Paiss T et al. Familial versus sporadic prostate cancer in the German population. Clinical and pathological characteristics in patients after radical prostatectomy. Urologe A 2003; 42: 946-953.
26. Stanford J et al. Surveilance, epidemiology and end results. (eds). In: Prostate Cancer Trends, 1973-1995. NCI: Bethesda, MD 1995.
27. Harlan L et al. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol 1995; 13: 93-100.
28. Reis-Starr C, Weinrich SP, Creanga D, Weinrich M. The association between family history and participation in free prostate cancer screening. Am J Health Studies 1998; 14: 95-104.
29. Bratt O, Kristofferson U, Lundgren R, Olsson H. Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening and genetic testing. Urology 1997; 50: 360-365.
30. Calle E, Flanders WD, Thun MJ, Martin LM. Demographic predictors of mammography and pap smear screening in U. S. women. Am J Public Health 1993; 83: 53-60.